OVERVIEW
The in-situ hybridization market is projected to reach USD 1.2 billion by 2024, rising at a CAGR of 4.67% during the forecast period. Growth in the overall market can be attributed to a growing diagnosis and incidence and prevalence of cancer, technical advances in therapeutics, and increase in global government initiatives.
TABLE OF CONTENT
1 Global In situ Hybridization MarketÂ
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global In situ Hybridization Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global In situ Hybridization Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global In situ Hybridization Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global In situ Hybridization Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global In situ Hybridization Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global In situ Hybridization Market – By Technique (Market Size – & million/billion)
8.1 Fluorescence In Situ Hybridization (FISH)
8.2 Chromogenic In Situ Hybridization
9 Global In situ Hybridization Market – By Application
9.1 Cancer Diagnosis
9.2 Immunology
9.3 Neuroscience
9.4 Cytology
9.5 Infectious Diseases
10 Global In situ Hybridization Market – By End-User
10.1 Molecular Diagnostic Laboratories
10.2 Pharmaceutical & Biotechnology Companies
10.3 Contract Research Organizations (CROs)
10.4 Academic & Research Institutions
11 Global In situ Hybridization Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global In situ Hybridization Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global In situ Hybridization Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 F.Hoffmann-La Roche Ltd.
13.3 Danaher Corporation / Leica Biosystems Nussloch GmbH
13.4 Thermofisher Scientific, Inc.
13.5 Perkin Elmer, Inc.
13.6 Merck KGaA
13.7 Agilent Technologies, Inc.
13.8 Biogenex Laboratories, Inc.
13.9 Advanced Cell Diagnostics, Inc
13.10 Exiqon A/S
13.11 Bio Sb, Inc.
13.12 Company 11 & more
14 Global In situ Hybridization Market – Appendix
14.1 Sources
14.2 Abbreviations